U.S. Stocks Rise on Iran Conflict Optimism as Eli Lilly Expands Sleep‑Disorder Focus

U.S. equities climbed on Thursday, buoyed by fresh optimism that diplomatic steps could bring an end to the ongoing Iran conflict. Traders cited the prospect of reduced geopolitical risk as a catalyst for the rally, especially as the market entered its final trading hour. The broader market sentiment reflected a shift from caution to cautious optimism, with investors re‑balancing portfolios in response to the potential easing of Middle‑East tensions. This sentiment was amplified by the timing of the Investing Club’s Homestretch update, which arrives just before the market close and often influences short‑term trading decisions. In parallel, Eli Lilly made headlines by unveiling a major initiative aimed at expanding its presence in the sleep‑disorder therapeutic space. While the company did not disclose specific financial metrics, the move signals a strategic diversification beyond its core offerings and could attract interest from both healthcare investors and specialty pharma analysts. The combined effect of geopolitical relief and sector‑specific news contributed to a noticeable uptick in trading volumes, particularly among market participants focused on the closing minutes of the session. Analysts suggest that the dual drivers may set a tone for the coming weeks, as investors watch for concrete developments on the Iran front and monitor Eli Lilly’s progress in its new therapeutic focus.